Summary
The purpose of the Connect® Myeloid disease registry is to provide unique insights into
treatment decisions and treatment patterns as they relate to clinical outcomes of
patients with myeloid diseases in routine clinical practice. This disease registry will
also evaluate molecular and cellular markers that may provide further prognostic
classification which may or may not be predictive of therapy and clinical outcomes.